Chemoinformaics analysis of 3-METHYL-6-PROPAN-2-YLCYCLOHEX-2-EN-1-OL
| Molecular Weight | 154.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 42 |
| Exact Molecular Weight | 154.136 | nRing | 1 |
| Solubility: LogS | -3.688 | nHRing | 0 |
| Solubility: LogP | 5.362 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.278 |
| Synth | 6.088 |
| Natural Product Likeliness | 2.067 |
| NR-PPAR-gamma | 0.078 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.044 |
| HIA | 0.005 |
| CACO-2 | -5.763 |
| MDCK | 0.0000189 |
| BBB | 0.109 |
| PPB | 0.8871 |
| VDSS | 0.726 |
| FU | 0.0819702 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.088 |
| CYP2c19-sub | 0.952 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.481 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.957 |
| CYP3a4-inh | 0.074 |
| CYP3a4-sub | 0.951 |
| CL | 6.493 |
| T12 | 0.263 |
| hERG | 0.975 |
| Ames | 0.082 |
| ROA | 0.216 |
| SkinSen | 0.876 |
| Carcinogencity | 0.03 |
| EI | 0.004 |
| Respiratory | 0.398 |
| NR-Aromatase | 0.72 |
| Antiviral | No |
| Prediction | 0.927017 |